Navigation Links
A new study of living cells could revolutionize the way we test drugs

Researchers have made a breakthrough by detecting the electrical equivalent of a living cell’s last gasp. The work takes them a step closer to both seeing the ‘heartbeat?of a living cell and a new way to test drugs.

To stay alive, individual biological cells must transfer electrically charged particles, called ions across their cell membranes. This flow produces an electrical current that could, in principle, be detected with sensitive enough equipment. The recognition of such electrical activity would provide a kind of ‘cellular cardiogram? allowing the daily functioning of the cell to be monitored in a similar way to a cardiograph showing the workings of a human heart.

With funding from the Engineering and Physical Sciences Research Council (EPSRC), Professor Andre Geim at the University of Manchester and his team have set out to make the first measurement of a cellular ‘heartbeat?

"Once we know the average or usual pattern of electrical activity in a cell, we can see how different drugs affect it," says Professor Geim. This would put an early safeguard into the system that could be applied long before the drug was tested on animals or even humans. In addition, the electrical activity test could be used to monitor the effects of pollution on naturally occurring micro-organisms in the environment.

To detect a cell’s normal activity, Andre Geim and fellow researchers modified apparatus used originally to detect weak magnetic fields in superconductors*. Unfortunately, these modifications reduced the sensitivity of the technique, and the normal activity of the yeast cell could not be detected. This is the first time such a technique has been used on a living cell.

Not to be defeated, the researchers went about livening things up. They chose to invoke what any self-respecting party-goer would: alcohol. "We added ethanol ?which is essentially vodka ?to provoke a response from the cell. Ethanol is known to increase the tra nsparency of cellular membranes which we hoped would give a signal we could detect," says Dr Irina Barbolina, who carried out the experiments.

It worked. As soon as the yeast got a taste of the vodka, the probe registered an electrical signal. A drunken hiccup perhaps? "It was probably the last gasp of the dying cell," says Professor Geim. The researchers had added so much ethanol that it poisoned the cell.

Although not the cardiogram they had hoped for, the electrical signal was the smallest yet detected from a living cell, around 100 times smaller than anything previously detected. It added up to an electrical current of just 10 moving electrons. It has given the team confidence that equipment sensitive enough to measure a cell’s heartbeat can be developed.

"We already have some ideas about how to improve the sensitivity of the detector in water and next time we will also use a more active micro-organism such as an amoeba. Yeast is a subdued organism and doesn’t generate much activity," says Professor Geim. "Probably, the most important outcome is that we defined an important goal. Cellular cardiograms can no longer be seen as absurd or science-fictional. If not us then someone else will soon develop a technique sensitive enough for such studies."
'"/>

Source:Engineering and Physical Sciences Research Council


Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
Breaking Biology News(10 mins):
(Date:2/28/2017)...  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company ... autoimmune diseases, asthma and allergic diseases and cancer, ... and full year ended December 31, 2016 and ... and clinical highlights. "During 2016, we ... by starting five clinical trials across our XmAb ...
(Date:2/28/2017)... ... February 28, 2017 , ... FireflySci is a small cuvette manufacturer ... late 2014, FFS had a mission to bring affordable and quality lab equipment to ... product that gives a lab everything needed to get started with using cuvettes. , ...
(Date:2/28/2017)... ... February 28, 2017 , ... ACEA Biosciences, a pioneer in cell analysis instrumentation ... Dr. Roger (Feng) Luo as the new Vice President of Global Clinical Development. ... drug companies, Dr. Luo will now team with Dr. Li Xu, Chief Medical Officer, ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen ... from millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. ... to express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology ...
Breaking Biology Technology: